Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response

Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response

ABSTRACTGut dysbiosis has been reported in chronic hepatitis B (CHB) infection, however its role in CHB progression and antiviral treatment remains to be clarified. Herein, the present study aimed to characterize gut microbiota (GM) in patients with chronic hepatitis B virus infection-associated liv...

Full description

Bibliographic Details
Main Authors: Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Gut Microbes
Subjects:
Chronic hepatitis B virus infection-associated liver disease
cirrhosis
antiviral treatment
microbiome
metabolome
peripheral immunity
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2022.2155018

Internet

https://www.tandfonline.com/doi/10.1080/19490976.2022.2155018

Similar Items